skip to content
Primary navigation

Tobramycin Inhalation Solution

DrugBethkis, Tobi, tobramycin inhalation solution

January 2018

Therapeutic area - Cystic Fibrosis

Preferred Product: Bethkis inhalation solution

Nonpreferred Products: Tobi, generic tobramycin inhalation solution

Criteria

Authorization will be granted for nonpreferred products if the recipient has had a documented:

  • Allergic reaction to a specific inactive ingredient in the preferred product
  • Adverse reaction to a specific inactive ingredient in the preferred product
  • Therapeutic success while taking the nonpreferred product and therapeutic failure while taking the preferred product
  • Supporting documentation must be provided at the time of request

Questions?

MHCP Provider Call Center 651-431-2700 or 800-366-5411

back to top